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Abstract — In 2013, the UK national renal registry established 
57,000 adults in the UK were treated for advanced kidney 
failure, 23,683 (42%) receiving haemodialysis. Haemodialysis 
patients face some of the highest treatment burden in the 
National Health Service (NHS) and are among the most 
‘expensive’ to treat. In addition, patients endure complex 
treatment trajectories.  In this study, we have sought to gather 
and synthesise the opinion of clinical and Human Computer 
Interaction (HCI) domain experts (n=9) to establish a set of 
initial design requirements in order to test the feasibility of 
developing a digital aid (i.e. electronic haemodialysis patient 
portal) to support patients in the course of their treatment. 
Expert feedback was gathered by means of interviews and focus 
groups in order to instruct design requirements for a 
haemodialysis patient portal.  
Keywords: advanced chronic kidney disease; patient portal; 
design requirements; experts study 
I.  INTRODUCTION 
Chronic kidney disease is a substantial global health 
burden with a very high associated economic cost to health 
systems [1]. It is a very significant independent risk factor for 
further morbidities, including cardiovascular diseases, 
premature mortality, and a substantial decrease in quality of 
life (QoL) [1-3].  
Furthermore, treatment options and trajectories for 
patients with advanced chronic kidney diseases (ACKD) are 
complex and subject to important and possibly unjustified 
variations. A recent mixed-methods national appraisal of 
haemodialysis (HD) vascular access (VA) provision in 
Scotland highlighted substantial variation in the use of 
different VA modalities between Scottish renal units [4] and 
patients reported frustration and dissatisfaction with their 
personal experiences of treatment. The study recommended 
better staff education, multidisciplinary focus on patient care, 
clinical pathway optimisation and improved measurements of 
clinical and patient outcomes to improve VA service quality 
and facilitate safer and more effective, patient-centred care 
[4].  
In this study, we have sought to address some of these 
recommendations, focusing on developing an electronic 
patient portal for patients with ACKD. In the initial stages of 
the ACKD portal development, we have sought to gather 
design requirements from domain experts (clinical and 
Human Computer Interaction (HCI)). This study focuses on 
reporting results from this design requirements elucidation 
phase and is structured as follows: background information 
on chronic kidney disease and HD in section II, methods in 
section III and study results in section IV. 
II. BACKGROUND  
Haemodialysis (HD) is a life-prolonging medical 
procedure carried out when kidneys no longer function 
normally, such as in the case of ACKD [5]. The patient's 
blood is mechanically filtered by a HD machine, removing 
excess fluid and waste products from the blood – a task 
conducted by the kidneys when functioning normally. 
Treatment is typically performed three times a week, sessions 
lasting four to five hours. HD requires a vascular access (VA) 
method for cannulation (i.e. insertion of 'tube' to access blood 
vessels). There are various VA methods currently used in 
clinical practice, and make for complex patient pathways and 
complications of VAs are also common [6-7].  
Studies have shown that HD places a high treatment 
burden on patients and contributes significantly to lower QoL 
[1-3]. A recent qualitative study found that UK patients on 
HD experienced a range of fluctuations in cognitive/physical 
well-being across the HD cycle, severe restrictions arising 
from the treatment schedule, and that HD had substantial 
emotional impact on patients, their families and social 
relationships [8]. These findings suggest that HD patients 
need additional support to manage their care using a holistic 
and patient-centred approach.  
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Electronic clinical portals have been shown to be very 
useful tools for continuity of care and multidisciplinary 
management of perioperative patients [9-11].  
III. METHODS  
A. Study Participants 
This study was conducted with the Queen Elizabeth 
University Hospital (QEUH) in Glasgow. This study was 
approved by the institutional ethics board at the University of 
Strathclyde in June 2018. The QEUH is a modern 1,677-bed 
acute hospital and hosts the largest renal service in Scotland. 
Nine domain experts were recruited and participated in a 
series of individual semi-structured interviews and "think-
aloud" focus group sessions.  
The experts who participated are described in Table 1. 
 
Table 1. Description of Domain Experts 
ID Profession Sex 
E1 Consultant, Vascular and Renal Transplant 
Surgery 
F 
E2 Consultant, Transplant and General Surgery  M 
E3 Consultant Nephrologist M 
E4 Locum Consultant, Clinical Research Fellow M 
E5 Consultant Nephrologist, Scottish Patient Safety 
Program Fellow  
M 
E6 Sociology Research Assistant, Qualitative 
Methods and Quality of Life 
F 
E7 Senior Academic ('associate professor' level), 
Digital Health 
M 
E8 Senior Academic ('associate professor' level), 
Digital Health 
F 
E9 Senior Academic ('associate professor' level), 
Human Computer Interaction (HCI) 
F 
B. Data Collection 
All participants (n=9) provided consent and participated 
in a total 12 interviews and focus groups. We initially 
conducted one-to-one semi-structured interviews (n=6) with 
clinical experts (E1-E6) to elucidate existing issues or 
limitations with the care of patients on HD and gather the 
portal system requirements. The semi-structured interviews 
allowed participants to begin discussions about issues and 
topics related to ACKD patient care.  
Once an initial patient portal prototype was developed, a 
set of focus groups was then conducted (n=6) to gather 
iterative expert feedback on the prototype, where specific 
functionalities were discussed in depth and then subsequently 
revised and updated prior to the next focus groups. All 
participants from the original interviews were invited back to 
provide feedback in these sessions along with (n=3) new 
participants regarded as experts in Digital Health or HCI (E7-
E9). Focus groups were conducted with up to 4 participants 
at a time, with 2 researchers present. The interviews and 
focus groups lasted an average time of 55 minutes and were 
all held on site (i.e. dedicated meeting room at QEUH) 
between June and November 2018.   
During the 'think-aloud' focus groups, participants could 
interact with the prototype, speaking aloud any thoughts or 
opinions as they completed tasks and investigated the 
prototype. Guidance and assistance were available if 
requested but participants were encouraged to explore the 
prototype independently and talk openly at the start of all 
sessions, with researchers allowing time for pause in 
discussion. 
 
C. Data Analysis 
The audio of all interviews and focus groups was digitally 
recorded with consent of participants and transcribed for 
analysis.  
We analysed the data using a health information systems 
quality assessment framework for coding the transcripts of 
interviews [12]. The framework is derived from DeLone & 
McLean's model of quality in information systems [13].  
The framework comprises the following 6 dimensions: (i) 
eHealth information system quality; (ii) information quality; 
(iii) information usage; (iv) user satisfaction; (iv) individual 
impact; and (vi) organisational impact. Through iterative 
amalgamation of related codes, new distinct themes emerged 
which we grouped into those described in section IV.A. 
IV. RESULTS 
A. Thematic Analysis of Requirements for a 
Haemodialysis Patient Portal 
T1: Information System Quality: Importance of Good and 
Simple Design.  
The clinicians interviewed confirmed HD patients faced 
significant treatment burden, and attended the hospital 
frequently and for significant time. They expected that 
patients would be keen to engage with a digital system that 
recorded their experiences, particularly during treatment as 
this could be a positive distraction during a lengthy 
procedure. They emphasised the need for a high-quality and 
simple design nevertheless, to maintain the patients' 
engagement over time while catering for the wide range of 
potential users, with varying levels of health and technical 
literacy present across the patient population. For example, it 
was stated by E1: "I think the reason people will do it, is if 
it's easy and pleasant to interact with. They won't do it for 
points or prizes or anything else, they'll do it because it's 
simple, easy and they feel they've bought into it and 
somebody's interested." 
 
T2: Information Quality: Inadequate or Missing Data. 
All clinical experts interviewed raised the issue that the 
current information systems in use provided incomplete and 
limited access to patient data and this prevented them from 
understanding how effective treatments provided were. It was 
noted that while some information was being recorded during 
the clinical encounters at the hospital, clinicians had limited 
insight into treatment burden in daily life and other aspects of 
'disease management' once patients left after HD sessions. 
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Examples of these issues included: no QoL data currently 
available in hospital information systems; location of VA 
cannulation during HD not appropriately recorded or 
available; recording of clinical events not always complete; 
no means of investigating impact of treatment decisions on 
patient QoL; staff occasionally rely on patients recalling 
treatment information (e.g. previous VA cannulation 
location). Missing and incomplete data was described by E2: 
"…That's data that is no lon- not recorded anywhere at the 
minute, on anything. Some of the clinic events may or may 
not be, hospital admissions or complications… Like if you 
have a bad cannulation or y'know, it hurts, it's not recorded 
anywhere. So, some of its recorded, some of it isn't at the 
minute…" 
 
T3: Information Usage: Measuring Care Quality and 
Generating New Insights on Treatments.  
Immediately related to the previous theme, this one 
regards the usage of information which would be provided by 
a more comprehensive capture of patient data. It was thought 
that this would enable better understanding of the quality of 
treatments and provide new insight by cross-referencing the 
new data with that already captured by existing hospital 
formation systems, as suggested by E1: "Actually, we can link 
that [data recorded by proposed system] by date by looking 
at their other stuff [existing patient data]- which is actually 
probably better…yeah so in terms of… - it's about being able 
to put them in the same place or link them at some point." 
 
T4: User Satisfaction: Simplifying and Clarifying 
Treatment Options for Patients.  
Clinicians confirmed patients were often confused by the 
range of treatment options available to them and this could 
lead to frustration and dissatisfaction with care they received 
noted previously [4]. This was partly blamed on the lack of a 
standardised overview of treatment options and care 
pathways. It was suggested by E3 that functionalities in a 
patient portal that guided patients through treatment options 
could lead to an improvement in patients’ understanding and 
satisfaction with their care:  "They don't feel like they're the 
expert in their care…It's about health literacy…A lot of the 
patients, they know what they're told by consultants, but they 
don't - They're just rehashing what they've been told. I've 
found patients are quite resistant to advise other patients…a 
lot of the time they would say, 'Oh, I'm not placed to advise 
anyone…’” 
 
T5: Individual Impact: Improving Patients Outcomes 
Measures.  
Clinicians emphasised better information capture and 
analysis as a driver for care quality improvement and better 
outcomes for patients. A key argument in support of a patient 
portal is the potential to allow tailored VA and treatment 
options depending on how each patient responds, which is 
very much aligned to current strategic priorities of 'person-
centred' care and 'personalised medicine’. For example, E6 
stated: "…what you want to see is, when the [vascular] access 
is good, is it very very good? And when it’s bad just how 
awful was it? And you can then say, 99 times out of a 100, 
it'll run fine. And you'll have a very, very good qualitative 
argument…" 
 
T6: Organisational Impact: Developing Optimal Care 
Pathways.  
In order to optimise patient care pathways, the benefits of 
a data-driven approach were discussed. Using new data 
sources such as patient outcomes measures (T5), clinicians 
would be able to support decisions and redesign regarding 
services and treatments. E2 discussed this in regards to future 
clinical trials and studies: "Ultimately it's about trying to pick 
out in a trial cohort where you've got two alternative 
strategies, what's worse for a patient…where you hope to see 
a difference is potentially the impact of different types of 
[vascular] access…" 
 
B. Formal Design Requirements for a Haemodialysis 
Patient Portal 
The thematic analysis was used to develop a formal set of 
'high-level' design requirements for the patient portal, which 
were discussed with the experts before the development of an 
initial prototype. The set of requirements is provided in Table 
2, including reference to relevant themes and issues analysed 
during the qualitative data analysis. 
 
Table 2. High-level formal requirements for Haemodialysis Patient 
Portal 
 Requirement Description Themes 
1 Capture of Quality of Life (QoL) measure T2, T5 
2 Capture of Important Clinical Events T2 
3 Capture of Vascular Access data T2 
4 Data Linkage between various data sources T3 
5 Data Processing: providing new insight into 
treatment impact 
T3, T5, T6 
 
6 Interactive treatment guide & patient care 
pathways 
T3, T4, T5 
7 System should be well designed, have high 
accessibility and usability to aid users with 
varying ability and experience 
T1, T4 
 
C. Haemodialysis Patient Portal Prototype Development 
& Expert Feedback 
A prototype patient portal system was developed using 
the formal design requirements and themes that emerged 
during the focus groups are described in detail and were used 
to further refine the portal requirements. Screenshots of the 
user interface of the prototype produced can be seen in Fig. 
1. We used the thematic analytical framework of Information 
Systems Quality [12-13] described in section III.C to analyse 
the feedback collated during focus groups. During the focus 
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groups, the experts provided feedback on: information added 
value, user interaction and accessibility.  
 
 Information Usage: Information Added Value.  
The format and analysis of potential data captured by the 
patient portal was discussed in depth. Additional suggestions 
were made for implementing further ‘analytic’ 
functionalities, including: sorting and filtering of data by 
date, level of QoL responses, clinical events, aspect of QoL, 
etc.; display data as timeline or graph over time, to highlight 
peaks, troughs and other patterns; display previous VA 
cannulation sites (unsuitable for current cannulation) during 
capture of cannulation data; and display QoL data alongside 
clinical events data, described by E2: "So what I'm looking 
for, there has to be an event as well…has anything happened, 
that tells you something… […] And the idea is presumably 
like if you have something like "access clots up" your Quality 
of life, y'know your Quality of Life plummets with that, 
y'know. And then it changes- we have to tailor, correlate that 
with clinical events, that's absolutely key."  
 
User Satisfaction: Insufficient Interaction Feedback.  
It was noted that the prototype did not offer sufficient 
feedback in some tasks, which was confusing for users. 
Experts suggested “pop-up” feedback could be implemented 
in order to communicate system status for functionalities 
such as the graft cannulation recorder or the QoL tool. Other 
suggestions included implementing audio and visual 
feedback and cues, such as ‘click’ sounds with users touching 
interface elements or animations drawing attention to 
important elements of the interface. 
 
User Satisfaction: Accessibility of Patient Portal.  
Experts provided positive feedback on the ‘minimalist’ 
interface which promoted efficient learning of the core 
functions of the system. Providing support for visual 
impairments was discussed in depth, as partial sight loss or 
complete blindness are common comorbidities associated 
with ACKD patients [16].   
For example, E8 discussed some accessibility measures: 
"That's what I was going to say, maybe more pictures and 
links…Like we can't just assume that people can read 
everything and sometimes its videos and things like that for 
people…it's so much more accessible… […]Could you have, 
link in the future, voice recognition?…it'll ask you the 
question and you answer it, nothing to do with text."  
Suggestions for additional accessibility functionalities 
included: text-to-speech audio output for visually impaired 
users; voice recognition for user input; recording of user 
settings or preferences (background colour, text font size, 
colour, etc.); adaptive user interface layouts to support user 
interaction with single available hand during HD treatment; 
alternative media alongside patient care pathways text 
information (e.g. images, audio, videos, etc.). 
V. CONCLUSION 
To the best of our knowledge, this study is the first to 
elucidate and define a set of formal requirements for the 
implementation of a clinical portal for ACKD 
patients/patients receiving HD treatment. While some 
requirements are likely generic to patient portal systems in 
general, some unique disease specific requirements were 
identified, including the need for VA specific QoL measure 
and the need to capture VA cannulation (Req. 1, 3). Other 
requirements highlighted that - although the functionalities 
could be construed as more generic - the real added value 
came from condition specific content (i.e. interactive 
treatment guides and patient care pathways, Req. 6) and 
condition specific analytics to assess disease trajectories and 
treatment impact (Req. 2-5). This suggests for high treatment 
burden conditions such as HD, capturing the idiosyncratic 
requirements inherent to the condition is essential for 
successful deployment of a patient portal designed for this 
patient group. We intend to test this hypothesis by conducting 
a follow-up study with HD patient groups in the near future. 
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Figure 1. Screenshots of Prototype Patient Portal: Dashboard; Quality of Life Tool; Graft Cannulation Recorder, Interactive Care Pathways. 
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